What you need to know about PANDAS and its treatment with Ethan Pompeo
- Brad
- 12 minutes ago
- 2 min read
Release date: April 14, 2025
Talking About Kids is committed to the science of raising happy and healthy children and adolescents. Unfortunately, there are times when the best research seems out of sync with the needs of families. For example, it is rare for me to encounter the parent of a neurodivergent kid who is completely satisfied with their child’s diagnosis or the care their child is receiving. This is especially true for kids whose issues are defined by a combination of symptoms, some of which may be contradictory or shared by multiple syndromes. My guest today is Ethan Pompeo. Ethan has pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections or PANDAS. In this episode, Ethan describes how his and his family’s inability to find a suitable treatment for him eventually led them to CBD. Ethan and I discuss PANDAS, his experience with CBD, what CBD is and is not, the state of the research on CBD as a treatment for PANDAS and other conditions, and how Ethan’s company, Green Valley Nutrition, is helping advance the science. While researchers from groups like the Harvard Medical School agree that the available studies of CBD are promising, the consensus in the scientific community is that there is more to learn, which is why you should review the evidence yourself and consult with the care team before introducing CBD into a kid’s treatment regimen. More information about Ethan and links to Green Valley Nutrition and the other resource we cite are below.
Biography of Ethan Pompeo
Ethan's life took a turn for the worst when he was diagnosed with an autoimmune disease called PANDAS as a kid. Now, his company is transforming the health and lives of others with simple, effective wellness solutions for the whole family.

Links
Green Valley Nutrition
Neuroimmune Foundation
PANDAS - Questions and Answers
Cannabidiol (CBD): What we know and what we don't
Emerging Therapeutic Potential of Cannabidiol (CBD) in Neurological Disorders: A Comprehensive Review
Comentarios